Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | Frm | Arm | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Philadelphia - ML
PHI - ML
|
2028 | 2B | 9 | 81.0 | 10 | 24 | 2 | .944 | 3.78 | .856 | - | - | -2.30 |
Philadelphia - ML
PHI - ML
|
2028 | 3B | 17 | 146.0 | 10 | 30 | 2 | .952 | 2.47 | .977 | - | - | -0.58 |
Philadelphia - ML
PHI - ML
|
2027 | 2B | 1 | 1.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | - | - | 0.00 |
Philadelphia - ML
PHI - ML
|
2027 | 3B | 86 | 733.1 | 46 | 192 | 17 | .933 | 2.92 | 1.030 | - | - | 4.20 |
Philadelphia - ML
PHI - ML
|
2027 | SS | 2 | 2.0 | 1 | 1 | 1 | .667 | 9.00 | .750 | - | - | -0.52 |
Philadelphia - ML
PHI - ML
|
2027 | CF | 2 | 3.0 | 2 | 0 | 0 | 1.000 | 6.00 | 1.999 | - | 0.0 | 0.69 |
Philadelphia - ML
PHI - ML
|
2026 | 2B | 2 | 4.0 | 1 | 3 | 0 | 1.000 | 9.00 | 1.354 | - | - | 0.56 |
Philadelphia - ML
PHI - ML
|
2026 | 3B | 132 | 1143.2 | 78 | 247 | 9 | .973 | 2.56 | 1.029 | - | - | 4.93 |
Philadelphia - ML
PHI - ML
|
2026 | SS | 5 | 8.0 | 2 | 1 | 1 | .750 | 3.38 | .667 | - | - | -0.52 |
Philadelphia - ML
PHI - ML
|
2026 | CF | 2 | 3.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | - | 0.0 | -0.00 |
Philadelphia - ML
PHI - ML
|
2024 | 2B | 1 | 2.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | - | - | 0.00 |
Philadelphia - ML
PHI - ML
|
2024 | 3B | 18 | 99.1 | 4 | 18 | 0 | 1.000 | 1.99 | 1.071 | - | - | 0.90 |
Philadelphia - ML
PHI - ML
|
2024 | SS | 2 | 2.0 | 1 | 0 | 0 | 1.000 | 4.50 | 1.002 | - | - | 0.00 |
Philadelphia - ML
PHI - ML
|
2024 | CF | 1 | 1.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | - | 0.0 | -0.00 |
Total | 2B | 13 | 88.0 | 11 | 27 | 2 | - | - | - | - | - | -1.74 | |
Total | 3B | 253 | 2122.1 | 138 | 487 | 28 | - | - | - | - | - | 9.45 | |
Total | SS | 9 | 12.0 | 4 | 2 | 2 | - | - | - | - | - | -1.04 | |
Total | CF | 5 | 7.0 | 2 | 0 | 0 | - | - | - | - | 0.0 | 0.69 |